Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2006-09-15

Clinical Trial Update: Surgical Removal of Idiopathic Epiretinal Membrane With and Without the Assistance of Indocyanine Green. [NA]

View source ↗

Summary

This clinical trial update notes the completion of a study evaluating surgical removal of idiopathic epiretinal membrane with and without indocyanine green dye.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: University of Regensburg | Conditions: Idiopathic Epiretinal Membrane, Cataract | NA | Status: COMPLETED